【结 构 式】 |
【分子编号】52258 【品名】methyl 4-{[4-(chlorocarbonyl)-2-(methyloxy)-5-nitrophenyl]oxy}butanoate 【CA登记号】 |
【 分 子 式 】C13H14ClNO7 【 分 子 量 】331.7094 【元素组成】C 47.07% H 4.25% Cl 10.69% N 4.22% O 33.76% |
合成路线1
该中间体在本合成路线中的序号:(VI)Vanillic acid (I) was alkylated with ethyl bromobutyrate (II) to afford ether (III). The ester function of (III) was then subjected to saponification, yielding diacid (IV). Nitration of (IV) gave the nitro compound (V). Selective esterification of the aliphatic carboxyl group of (V) was achieved employing p-toluenesulfonic acid in methanol, and the resultant mono-acid was further converted to the corresponding acid chloride (VI) upon treatment with oxalyl chloride. Coupling of acid chloride (VI) with (S)-pyrrolidine-2-carbaldehyde diethyl dithioketal (VII) provided amide (VIII). After the reduction of the nitro group of (VIII) by means of SnCl2, the resultant amino compound (IX) was protected as the N-Fmoc derivative (X). Thioketal deprotection of (X) with concomitant cyclization in the presence of HgCl2 and CaCO3 gave rise to the pyrrolobenzodiazepinone system (XI). The methyl ester of (XI) was then hydrolyzed under acidic conditions to furnish acid (XII).
【1】 Zhou, Q.; et al.; Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent. J Am Chem Soc 2001, 123, 20, 4865. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17786 | 4-hydroxy-3-methoxybenzoic acid; Vanillic acid | 121-34-6 | C8H8O4 | 详情 | 详情 |
(II) | 11263 | ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate | 2969-81-5 | C6H11BrO2 | 详情 | 详情 |
(III) | 52255 | 4-{[4-(ethyloxy)-4-oxobutyl]oxy}-3-(methyloxy)benzoic acid | C14H18O6 | 详情 | 详情 | |
(IV) | 52256 | 4-[(3-carboxypropyl)oxy]-3-(methyloxy)benzoic acid | C12H14O6 | 详情 | 详情 | |
(V) | 52257 | 4-[(3-carboxypropyl)oxy]-5-(methyloxy)-2-nitrobenzoic acid | C12H13NO8 | 详情 | 详情 | |
(VI) | 52258 | methyl 4-{[4-(chlorocarbonyl)-2-(methyloxy)-5-nitrophenyl]oxy}butanoate | C13H14ClNO7 | 详情 | 详情 | |
(VII) | 52259 | 2-[bis(ethylsulfanyl)methyl]pyrrolidine; ethyl (ethylsulfanyl)(2-pyrrolidinyl)methyl sulfide | C9H19NS2 | 详情 | 详情 | |
(VIII) | 52260 | methyl 4-{[4-({2-[bis(ethylsulfanyl)methyl]-1-pyrrolidinyl}carbonyl)-2-(methyloxy)-5-nitrophenyl]oxy}butanoate | C22H32N2O7S2 | 详情 | 详情 | |
(IX) | 52261 | methyl 4-{[5-amino-4-({2-[bis(ethylsulfanyl)methyl]-1-pyrrolidinyl}carbonyl)-2-(methyloxy)phenyl]oxy}butanoate | C22H34N2O5S2 | 详情 | 详情 | |
(X) | 52263 | methyl 4-{[4-({2-[bis(ethylsulfanyl)methyl]-1-pyrrolidinyl}carbonyl)-5-({[(9H-fluoren-9-ylmethyl)oxy]carbonyl}amino)-2-(methyloxy)phenyl]oxy}butanoate | C37H44N2O7S2 | 详情 | 详情 | |
(XI) | 52262 | 9H-fluoren-9-ylmethyl 11-hydroxy-7-(methyloxy)-8-{[4-(methyloxy)-4-oxobutyl]oxy}-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate | C33H34N2O8 | 详情 | 详情 | |
(XII) | 52264 | 4-{[10-{[(9H-fluoren-9-ylmethyl)oxy]carbonyl}-11-hydroxy-7-(methyloxy)-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy}butanoic acid | C32H32N2O8 | 详情 | 详情 |